Downregulation of the following has also been identified: RNY1, RNY3, RNY4, and RNY5 in prostate (tissue) and bladder cancer (tissue) and RNY1 (blood serum) in head and neck squamous cell carcinoma. This evidence concerns the gene RNY1 and urinary bladder cancer.